CD74 and neoplasm: Importantly, tumor cells from patients with EGFR mutation showed increased expression of several MHC class I and II genes compared to tumor cells from patients with KRAS mutant tumors, along with an increase in CD74, which regulates the presentation of MHC class II proteins (Fig. 2i).